DIAGNOSTIC VALUE OF ANGIOGENESIS RATES IN RENAL-CELL CARCINOMA
https://doi.org/10.17650/1726-9776-2011-7-3-25-30
Abstract
The results of research in 130 patients with space-occupying lesions of kidneys treated in MCH n.a. S.R. Mirotvorcev were analysed. The diagnostic significance of metabolic tumor marker TuM2Pk, matrix metalloproteinases ММР-9, ММP-3, vascular endothelial growth factor (VEGF) and angiogenic cytokines (TNF-α, IL-8, IL-12) was evaluated. It was determined that VEGF detection in blood serum has the most important diagnostic value in differential diagnosis between renal tumor and renal cyst and in TNM staging.
About the Authors
P. V. Glybochko
I.M. Sechenov First Moscow Medical University
Russian Federation
Russian Federation
N. B. Zacharova
State Medical Univercity n.a. V.I. Razumovskiy
Russian Federation
Russian Federation
A. N. Ponukalin
State Medical Univercity n.a. V.I. Razumovskiy
Russian Federation
Russian Federation
D. A. Durnov
State Medical Univercity n.a. V.I. Razumovskiy
Russian Federation
Russian Federation
N. K. Shachpazyan
State Medical Univercity n.a. V.I. Razumovskiy
Russian Federation
Russian Federation
References
1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005;55:74–108.
2. Skinner D.G., Colvin R.B., Vermilion C.D. et al. Diagnosis and anagement of renal cell carcinoma. Cancer 1971;28:1165–77.
3. Weyman P.J., McClennan B.L., Stanley R.J. et al. Comparison of CT and angiography in the evaluation of renal cell carcinoma. Radiology 1980; 137:417–24.
4. Злокачественные новообразования в России в 2008 году. Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. М., 2010.
5. Клиническая онкоурология. Под ред. Б.П. Матвеева. М.: Вердана, 2003. 716 с.
6. Cohen H.T., McGovern F.J. Renal-cell carcinoma. N Engl J Med 2005; 353:2477–90.
7. Parton M., Gore M., Eisen T. Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer. J Clin Oncol 2006;24:5584–92.
8. Аляев Ю.Г., Крапивин А.А. Резекция почки при раке. М.: Медицина, 2001. 222 с.
9. Ахмедов Б.П. Метастатические опухоли. М.: Медицина, 1984. 46 с.
10. Чиссов В.И., Старинский В.В., Ременник Л.В. Основные показатели состояния онкологической помощи населению Российской Федерации в 1994 году. М., 1995. 163 с.
11. Oremek G.M., Teigelkamp S., Kramer W. et al. The pyruvate kinase isoenzyme Tumor M2 (TuM2Pk) as a tumor marker for renal carcinoma. Anticancer Res 1999;19:2599–602.
12. Мовсесян В.В. Диагностическая значимость опухолевого маркера TuM2Pk при новообразованиях почки. Дис. … канд. мед. наук. М., 2006.
13. Sato K., Tsuchiya N., Sasaki R et al. Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma. Jpn J Cancer Res 1999; 90(8):874–9.
14. McMahon G. VEGF receptor signaling in tumor angiogenesis. The Oncologist 2000;5:11:3–10.
15. Motzer R.J., Michaelson M.D., Redman B.G. et al. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol 2006;24:16–24.
16. Bergers G., Benjamin L.E. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003;3:401–10.
17. Oremek G.M., Bickeboller R., Seiffert U.B. et al. Aussagekraft des neuen Tumormarkers Tumor M2-Pk bei Patiented mit Hodentumor 12. Symposium für Experimentelle Urologie. Berlin, 1995.
18. Трапезникова М.Ф., Глыбин П.В., Туманян В.Г. и др. Фактор роста эндотелия сосудов и его рецептор 2-го типа в сыворотке крови, опухоли и паренхиме почки больных почечно-клеточным раком. Урология 2010;4:3–7.
19. Schneider J., Schulze G. Anticancer Res 2003;23:5089–94.
20. Paradis V., Lagha N.B., Zeimoura L. et al. Expression of vascular endothelial growth factor in renal cell carcinomas. Virchows Arch 2000; 436(4):351–6.
21. Kerbel R., Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002; 2:727–39.
Review
For citations:
Glybochko P.V., Zacharova N.B., Ponukalin A.N., Durnov D.A., Shachpazyan N.K. DIAGNOSTIC VALUE OF ANGIOGENESIS RATES IN RENAL-CELL CARCINOMA. Cancer Urology. 2011;7(3):25-30. (In Russ.) https://doi.org/10.17650/1726-9776-2011-7-3-25-30
Views:
661
Email this article 